Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

Detalles Bibliográficos
Autores principales: Spanjaart, Anne Mea, Ljungman, Per, de La Camara, Rafael, Tridello, Gloria, Ortiz-Maldonado, Valentín, Urbano-Ispizua, Alvaro, Barba, Pere, Kwon, Mi, Caballero, Dolores, Sesques, Pierre, Bachy, Emmanuel, Di Blasi, Roberta, Thieblemont, Catherine, Calkoen, Friso, Mutsaers, Pim, Maertens, Johan, Giannoni, Livia, Nicholson, Emma, Collin, Matthew, Vaz, Carlos Pinho, Metafuni, Elisabetta, Martinez-Lopez, Joaquin, Dignan, Fiona L., Ribera, Josep-Maria, Nagler, Arnon, Folber, Frantisek, Sanderson, Robin, Bloor, Adrian, Ciceri, Fabio, Knelange, Nina, Ayuk, Francis, Kroger, Nicolaus, Kersten, Marie José, Mielke, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573311/
https://www.ncbi.nlm.nih.gov/pubmed/34750508
http://dx.doi.org/10.1038/s41375-021-01466-0

Ejemplares similares

Ejemplares similares